NEURAXIS, INC.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | — | $3.6M | $2.7M | $2.5M | $2.7M |
| Cost of Revenue | — | $562.9K | $362.0K | $303.3K | $297.1K |
| Gross Profit | — | $3.0M | $2.3M | $2.2M | $2.4M |
| Gross Margin | — | 84.2% | 86.5% | 87.7% | 88.9% |
| Operating Expenses | |||||
| Research & Development | — | $493.6K | $433.6K | $169.3K | $225.6K |
| SG&A Expense | — | $8.1M | $7.6M | $8.3M | $5.1M |
| Operating Income | — | $-7.8M | $-7.2M | $-6.7M | $-3.4M |
| Operating Margin | — | -219.4% | -266.5% | -270.9% | -125.6% |
| Interest Expense | — | $74.0K | $174.3K | $476.4K | $318.7K |
| Pretax Income | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — |
| Net Income | — | $-7.8M | $-8.2M | $-14.6M | $-4.8M |
| Net Margin | — | -218.5% | -306.8% | -594.6% | -178.0% |
| EPS (Basic) | — | $-0.95 | $-1.22 | $-2.25 | $-1.39 |
| EPS (Diluted) | — | $-0.95 | $-1.22 | $-2.25 | $-1.39 |
| Shares Outstanding (Basic) | 11.2M | 9.1M | 6.9M | 6.5M | 4.0M |
| Shares Outstanding (Diluted) | 11.2M | 9.1M | 6.9M | 6.5M | 4.0M |
| Dividends Per Share | — | — | — | — | — |